The FDA has approved drug label changes to six menopausal hormone replacement therapies (HRT), according to a recent news release. This was done to clarify risks for taking these drugs, specifically ...

The new labeling for the products does not include risk statements related to cardiovascular disease, breast cancer and probable dementia, the agency said.

Feb 12 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved labeling changes to six menopause ...

The move to ease the restrictions was backed by The Menopause Society (TMS), which said the boxed warning "may have been a deterrent to the use of the low-dose vaginal estrogen, which is a safe and ...

The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk considerations for ...

HRT can also be a concern after treatment. If you’ve been treated for HR+ breast cancer, “There is always some small risk ...

The FDA approved changes to the labels for six menopausal hormone therapy products in a move the agency said clarifies risk ...

If you’re navigating perimenopause or menopause—night sweats, brain fog, mood swings, weight gain, disrupted sleep (all potential symptoms)—you may have heard about hormone therapy, including ...

When going through perimenopause and menopause, you’ll likely experience hot flashes, mood swings and other symptoms. This is because your body is changing and your hormone levels are fluctuating. To ...

Testosterone, often referred to as the "happy hormone," is being hailed as a game changer in hormone replacement therapy for ...

As we age, natural hormone levels decline and can fall out of balance, affecting both men and women with symptoms like low ...

BoomRx, the fastest-growing national pharmaceutical technology platform that simplifies prescription sourcing and fulfillment, today announced the availability of an oral liquid testosterone ...